---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-006431"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2022-02-10T23:59:59+00:00"
generated_at: "2026-06-27T09:17:49.802762+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Health Sciences Acquisitions 2 restates financial statements due to equity classification error

## Summary
- Audit committee concludes all ordinary shares should be classified as temporary equity, not permanent.
- Restatement covers six prior filings from August 2020 through September 2021, including IPO balance sheet.
- No impact on cash position or trust account; earnings per share presentation also revised.
- Material weakness in internal control over financial reporting identified; disclosure controls ineffective.
- Company plans to file amended 10-K, 10-Q, and 8-K to correct the affected periods.

## SEC filing metadata
- accession: 0001213900-22-006431
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2022-02-10T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 4.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000121390022006431/0001213900-22-006431-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000121390022006431/ea155233-8k_healthsci2.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-006431
- JSON: https://secwatch.observer/filing/0001213900-22-006431.json
- Plain text: https://secwatch.observer/filing/0001213900-22-006431.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.